SEPHS2 and acute myeloid leukemia: Similarly, abnormal upregulation of selenium uptake and selenocysteine biosynthesis occurs in many cancer cells, including breast cancers (Carlisle et al., 2020) and acute myeloid leukemia (Eagle et al., 2022), making SEPHS2 crucial for their survival but not for normal cells.